InvestorsHub Logo
Followers 31
Posts 2649
Boards Moderated 0
Alias Born 10/28/2013

Re: chinatown1980 post# 59565

Sunday, 04/24/2016 11:05:19 AM

Sunday, April 24, 2016 11:05:19 AM

Post# of 711633
"Cognates manufacturing of stem cells"

The DC's for DCVax-L and Direct are grown from stem cells extracted from the patient's blood. I don't know whether that is what the text you are pointing to is talking about, or not.

If not... counter to what I have seen posted here, I think it was understood from early on that Cognate would be serving many customers. For a bear, that is evidence that Cognate is just using NWBO to stay afloat, but to a bull, it also makes total sense. NWBO needs to show the ability to mfg on a large scale to gain approval for therapies that are applicable on a large scale. It does not makes sense to attempt to keep such a large facility afloat and growing with only the business they would receive from NWBO during these trials. If approval is gained, there will be a large jump in the needed floorspace and personel to meet production needs. They cannot make that jump fast enough starting from the small levels of production capability needed to support the current trials. So... they fill up their facilities with as many other contracts as they can get, but keep the contracts flexible enough to allow changeover to NWBO products at a pace that would satisfy everyone, if that need arises.

You failed to rub LP's halo. That is why you cannot see these things as clearly as I do. It's magic!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News